Back
Apellis Pharmaceuticals, Inc. Vs. Nektar Therapeutics Industry Stock Comparison
Buy
56
APLS
Apellis Pharmaceuticals, Inc.
Last Price:
$24.66
Seasonality Move:
7.92%
Sell
46
NKTR
Nektar Therapeutics
Last Price:
$46.82
Seasonality Move:
6.44%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS)
is a Buy
Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.65. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APLS Stock Price Chart
What is Apellis Pharmaceuticals, Inc.'s stock price today?
-
The Apellis Pharmaceuticals, Inc. share price today is $24.65The current trend is moderately bullish and APLS is experiencing slight selling pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $46.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.85 | Buy |
| Relative Strength Index (14 RSI): | 60.12 | Buy |
| Chaikin Money Flow: | -939265 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.22 - 24.44) | Buy |
| Bollinger Bands (100): | (21.29 - 27.05) | Buy |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.95 | Sell |
| Relative Strength Index (14 RSI): | 38.83 | Sell |
| Chaikin Money Flow: | 857593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.69 - 61.39) | Sell |
| Bollinger Bands (100): | (34.99 - 62.73) | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.88 | Sell |
| 20-day SMA: | 22.96 | Buy |
| 50-day SMA: | 23.11 | Buy |
| 200-day SMA: | 21.9 | Buy |
| 8-day EMA: | 24.53 | Buy |
| 20-day EMA: | 23.51 | Buy |
| 50-day EMA: | 23.11 | Buy |
| 200-day EMA: | 24.27 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.29 | Sell |
| 20-day SMA: | 55.51 | Sell |
| 50-day SMA: | 57.37 | Sell |
| 200-day SMA: | 31.53 | Buy |
| 8-day EMA: | 49.58 | Sell |
| 20-day EMA: | 53.48 | Sell |
| 50-day EMA: | 54.29 | Sell |
| 200-day EMA: | 38.34 | Buy |
Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
Apellis Pharmaceuticals, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||